Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories
Deals
Features
News
Region
Sectors
Size

Page 2

Talking Tech Transfer: Sean Fielding
On this week’s episode of the Talking Tech Transfer podcast we are joined by Sean Fielding, who was, until a couple of weeks ago, the director of innovation, impact and business at University of Exeter. He tells us about building a tech transfer office from scratch in the mid-90s, how the requirement to generate impact […]
Talking Tech Transfer: Paul Van Dun
In this week’s episode of the Talking Tech Transfer podcast we are joined by Paul Van Dun, the general manager of Leuven Research and Development, the tech transfer office of KU Leuven, which has a unique framework that allows faculty to generate income for their labs without incorporating spinouts. Van Dun tell us more about this […]
Talking Tech Transfer: Brijesh Roy
In this week’s episode of the Talking Tech Transfer podcast we welcome Brijesh Roy, seed investment manager at Imperial College London, who started out in hedge fund management before joining Oxford University Innovation and then Mercia. He tells us about his storied career, why Imperial decided to bring spinout funding back in-house following the Touchstone […]
CVCs poised to benefit from positive momentum
The effective equality between public and private capital markets is almost complete.
The documentation of inventions during spinout
Careful documentation of inventive activity during the early stages of a spinout are important to avoid legal complications.
Albotherm seeds a green future
Based on research at University of Bristol, Albotherm’s technology could revolutionise how greenhouses and buildings are cooled.
TenU Hosts Regional Opportunities: four key messages
George Baxter of Edinburgh Innovations chaired TenU’s fourth event, leading a discussion on growing regional innovation hubs.
Isolere Bio breaks the biomanufacturing bottleneck
Co-founder and CEO Kelli Luginbuhl talks to GUV about how the Duke spinout re-imagines the manufacturing of complex biologics.
Imperial reignites funding operation
The institution is starting afresh with its investment activities, having brought the management of its spinouts back in-house after Touchstone.
H1 2021: a period without precedent
Investors have ploughed almost as much money into spinouts in the first six months of the year as they did for all of 2020.

test reg

Login